Genolution exports COVID-19 nucleic acid extraction reagents worth 1.9 billion KRW to Colombia
[Asia Economy Reporter Minwoo Lee] Genolution announced on the 14th that it has signed a contract worth 1.9 billion KRW to sell nucleic acid extraction reagents for the novel coronavirus (COVID-19) with Colombia's QUIMIOLAB S.A.S. The contract amount is 1,894,460,000 KRW. This corresponds to 47.95% of the consolidated sales in 2019.
Hot Picks Today
At President Lee's Call to "Give Enough to Shock," Whistleblower Rewards Become a Real Lottery
- If a Samsung Electronics Employee with a 100 Million Won Salary Receives a 600 Million Won Performance Bonus, Taxes Total 247.19 Million Won
- Lived as Family for Over 30 Years... Daughter-in-Law Cast Aside After Husband's Death
- "White House Blocks Repatriation of 'Ebola-Infected' Doctor... Ultimately Transferred to Germany"
- "4.15 Million Won Prada Jacket Shows White Spots After One Wear"...Korea Consumer Agency Orders Full Refund
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
